June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
βA3/A1-Crystallin/SLC36A4/V-ATPase complex in the RPE is a novel therapeutic target for AMD
Author Affiliations & Notes
  • Peng Shang
    Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
    Tongji Eye Institute, Tongji University, Shanghai, China
  • Mallika Valapala
    Indiana University School of Optometry, Bloomington, Indiana, United States
  • Stacey L Hose
    Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Jun Wan
    Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Jiang Qian
    Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Yuri V Sergeev
    National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States
  • J. Samuel Zigler, Jr.
    Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Debasish Sinha
    Ophthalmology, Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
  • Footnotes
    Commercial Relationships   Peng Shang, None; Mallika Valapala, None; Stacey Hose, None; Jun Wan, None; Jiang Qian, None; Yuri Sergeev, None; J. Samuel Zigler, Jr., None; Debasish Sinha, None
  • Footnotes
    Support  This work was supported by funding from National Eye Institute, National Institutes of Health grant EY019037-S (DS), BrightFocus Foundation (DS) and Research to Prevent Blindness (unrestricted grant to Wilmer Eye Institute).
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3384. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peng Shang, Mallika Valapala, Stacey L Hose, Jun Wan, Jiang Qian, Yuri V Sergeev, J. Samuel Zigler, Jr., Debasish Sinha; βA3/A1-Crystallin/SLC36A4/V-ATPase complex in the RPE is a novel therapeutic target for AMD. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3384.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We have previously demonstrated that βA3/A1-crystallin in the RPE is localized to the lysosomal lumen, where it regulates endo-lysosomal acidification by binding to ATP6V0A1/V0-ATPase. It is now clear that amino acids and V-ATPase are essential for mechanistic target of rapamycin, complex 1 (mTORC1) signaling. This study investigated whether βA3/A1-crystallin interacts with the amino acid transporter SLC36A4 (solute-linked carrier 36 family, member 4) and thereby regulates the amino acid pool in the lysosomes of RPE.

Methods : Co-immunoprecipitation was performed to investigate the binding between βA3/A1-crystallin and SLC36A4. An L-amino acid quantification kit was used to measure intracellular L-amino-acid concentration in RPE cells from both Cryba1fl/fl (control) and Cryba1 (gene encoding βA3/A1-crystallin) knockout (KO) mice. Autophagy was induced by 24h fasting of animals or by withholding serum and L-glutamine from cell cultures to investigate the mTORC1 pathway.

Results : We showed that βA3/A1-crystallin binds to SLC36A4 in RPE cells from Cryba1fl/fl mice, but not in cells from Cryba1 KO mice. SLC36A4 expression both at the mRNA and protein level was down-regulated in Cryba1fl/fl mice after 24h fasting. However, in Cryba1 KO mice, SLC36A4 expression was up-regulated after 24h fasting. Cryba1 KO mice appear to have a lower basal level of SLC36A4 expression compared to control mice. Our data also indicate that after 24h fasting the concentration of L-amino acids in RPE cells of Cryba1 KO mice was elevated, whereas this increase was not seen in RPE cells of Cryba1fl/fl mice. After autophagy induction, the level of phosphorylated mTORC1(Ser2448) and phosphorylated p70s6k (T421/S424) decreased in RPE cells of Cryba1fl/fl mice, but stayed at consistently higher levels in RPE cells of Cryba1 KO mice, suggesting mTORC1 activation and autophagy inhibition in Cryba1 KO RPE cells. Moreover, the protein levels of Ragulator and Rag GTPases were generally higher in Cryba1 KO mice, especially after autophagy induction.

Conclusions : We observed that βA3/A1-crystallin binds to SLC36A4, providing a direct link between amino acid availability and mTORC1 signaling. Therefore, targeting the βA3/A1-crystallin/SLC36A4/V-ATPase complex in the RPE may be an effective means of preventing or delaying the progression of age-related macular degeneration.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×